Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells - No Study Results Posted

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (CLIPA)

This study is currently recruiting participants.

Study NCT00078520 Information provided by Baylor College of Medicine

First Received: March 1, 2004 Last Updated: January 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2026
Estimated Primary Completion Date:	December 2026 (Final data collection date for primary outcome measure)